Fda inspection policy and best gmp practices
This presentation is the property of its rightful owner.
Sponsored Links
1 / 6

FDA Inspection Policy and Best GMP Practices PowerPoint PPT Presentation


This seminar is intended to discuss what FDA-regulated industry should know about FDA’s inspection policy to better implement the best Good Manufacturing Practices (GMPs). The common deficiencies found based on 483s issued to medical device and pharmaceutical industries will be discussed. The most common deficiencies are based on the speaker’s analysis of 483s issued for the past eight (8) years.This presentation will greatly help you better prepare for and manage an FDA inspection in a proactive and effective manner.  The speaker will also discuss practical, actionable, and sustainable guidance on how to prepare for a sustainable FDA inspection and how to manage the FDA inspection process including Dos and Don’ts before, during and after the inspection. 

Download Presentation

FDA Inspection Policy and Best GMP Practices

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Fda inspection policy and best gmp practices

FDA Inspection Policy and Best GMP Practices

Speaker: David Lim| Date: 10th November 2016 2016 2016 | 10:00 AM PST | 01:00 PM EST

Contact Us : Email: [email protected] | Tel: +1-248-233-2049


Description

This seminar is intended to discuss what FDA-regulated industry should know about FDA’s inspection policy to better implement the best Good Manufacturing Practices (GMPs). The common deficiencies found based on 483s issued to medical device and pharmaceutical industries will be discussed. The most common deficiencies are based on the speaker’s analysis of 483s issued for the past eight (8) years.

This presentation will greatly help you better prepare for and manage an FDA inspection in a proactive and effective manner. The speaker will also discuss practical, actionable, and sustainable guidance on how to prepare for a sustainable FDA inspection and how to manage the FDA inspection process including Dos and Don’ts before, during and after the inspection. 

Description:


Areas covered in the session

  • Applicable Laws and Regulations

  • FDA Manuals and Inspection Guides

  • Hosting an FDA Inspection

  • Inspection Types and Categories

  • Inspection Classification

  • FDA Forms 482 and 483

  • Common deficiencies in 483s

  • What/How to Prepare for and Manage an FDA Inspection

  • How to Communicate Before, During and After inspection: Dos and Don’ts

  • Inspection Preparation Procedures

Areas Covered in the Session:


Who will benefit

  • CEOs

  • VPs

  • Compliance Officers

  • Attorneys

  • Regulatory Affairs

  • Clinical Affairs

  • Quality Assurance

  • R&D

Who will benefit:


Instructor profile

Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Doctor (www.RegulatoryDoctor.us). As a leading industry speaker, Dr. Lim frequently presents global regulatory and quality compliance topics in various forums and meetings. Recently, Dr. Lim developed 510(k) templates ready for use compliant with e-Copy and RTA policy. In addition, Dr. Lim developed FDA inspection checklists for drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in 483s for the past eight years. Dr. Lim provides his feedback to regulatory agency (e.g., US FDA) through public comments and also served as a panel member during the FDA’s transparency public meeting in 2009.

Dr. Lim contributes to the Regulatory Affairs Professional Society (RAPS) as an author and speaker. Dr. Lim leads and directs all research projects including pharmacovigilance, medical device reporting, recalls and patient safety signals being conducted at the Regulatory Doctor. Dr. Lim currently serves as a member of the Advisory Board for Inspection Insider published by FDA News.

Instructor Profile :


  • Login